Is this you? Create Your Porfile
Avatar

Goodman Simon

Merck & Co.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Goodman Simon is active.

Explore More

Publication

Featured researches published by Goodman Simon.

Archive | 1999

MONOCLONAL ANTIBODY ANTI .ALPHA.V-INTEGRIN AND ITS USE TO INHIBIT .ALPHA.V.BETA.6-INTEGRIN ATTACHMENT TO FIBRONECTIN

Goodman Simon; Diefenbach Beate; Mitjans Francesc; Carceller Ana; Rosell-Vives Elisabet

Archive | 2002

Harnstoff- und Urethanderivate

Staehle Wolfgang; Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2001

Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶

Jonczyk Alfred; Diefenbach Beate; Goodman Simon

Archive | 2003

BIPHENYL THIOAMIDES SERVING AS INTEGRIN RECEPTOR ANTAGONISTS

Staehle Wolfgang; Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2002

alphavbeta3 integrin inhibitors

Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2001

Novel integrin alpha v beta 3 inhibitors

Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2000

Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor

Jonczyk Alfred; Perschl Astrid; Goodman Simon; Roesener Sigrid; Haunschild Jutta

Archive | 2003

Cyclopeptide derivative, process of its preparation and pharmaceutical preparation in which the derivative is comprised

Jonczyk Alfred; Goodman Simon; Diefenbach Beate; Koppitz Marcus; Kesler Horst

Archive | 2002

CHROMENONE AND CHROMANONE DERIVATIVES AS INTEGRIN INHIBITORS, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Fittschen Claus; Goodman Simon; Maerz Joachim; Raddatz Peter; Wiesner Matthias

Archive | 2002

New glycine N-(1-biphenyl-4-yl-2-substituted-ethyl)-amides, are integrin receptor inhibitors useful for treating e.g. angiogenic, cardiovascular, inflammatory and osteolytic or tumor diseases

Staehle Wolfgang; Jonczyk Alfred; Schadt Oliver; Goodman Simon

Explore More

Collaboration

Dive into the Goodman Simon's collaboration.

Top Co-Authors
Avatar

Jonczyk Alfred

Merck

View shared research outputs
Top Co-Authors
Avatar

Diefenbach Beate

Merck

View shared research outputs
Top Co-Authors
Avatar

Schadt Oliver

Merck

View shared research outputs
Top Co-Authors
Avatar

Staehle Wolfgang

Merck

View shared research outputs
Top Co-Authors
Avatar

Wiesner Matthias

Merck

View shared research outputs
Top Co-Authors
Avatar

Kessler Horst

Merck

View shared research outputs
Top Co-Authors
Avatar

Mitjans Francesc

Merck

View shared research outputs
Top Co-Authors
Avatar

Hahn Diane

Merck

View shared research outputs
Top Co-Authors
Avatar

Adan Jaume

Merck

View shared research outputs
Top Co-Authors
Avatar

Fittschen Claus

Merck

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge